Sherbrooke Park Advisers’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,087
Closed -$242K 579
2024
Q4
$242K Sell
29,087
-8,781
-23% -$64.8K 0.08% 501
2024
Q3
$225K Sell
37,868
-82,640
-69% -$460K 0.05% 703
2024
Q2
$634K Buy
120,508
+82,210
+215% +$419K 0.11% 310
2024
Q1
$208K Buy
38,298
+22,761
+146% +$145K 0.04% 710
2023
Q4
$114K Buy
+15,537
New +$102K 0.05% 389

Other funds holding ADTN

Sherbrooke Park Advisers's ADTN Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Adtran (ADTN) in Q1 2025, closing a stake of 29,087 shares — an estimated $242K sold.

Sherbrooke Park Advisers first reported a position in ADTN in Q4 2023 and held it in 5 quarters. The position peaked at $634K in Q2 2024. 205 funds tracked by Wall St. Rank hold ADTN as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Adtran position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 29,087 Adtran shares in Q1 2025, an estimated $242K.
  • Sherbrooke Park Advisers first reported a position in Adtran in Q4 2023 and held it in 5 quarters.
  • Sherbrooke Park Advisers's Adtran position peaked at $634K in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Adtran as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.